Myriad Genetics Inc Long-term Investment Intensity
Myriad Genetics Inc long-term investment intensity. Myriad Genetics Inc (MYGN) has a Long-term Investment Intensity of 0.5% as of June 2023. Long-term investments of $6.20 Million represent 0.5% of total assets of $1.19 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read total liabilities of Myriad Genetics Inc for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Myriad Genetics Inc (2019–2022)
Long-term investment intensity of Myriad Genetics Inc from 2019 to 2022. This chart shows how Myriad Genetics Inc's Long-term Investment Intensity has evolved across 3 annual periods from 2019 to 2022. As of June 2023, the intensity stands at 0.5%, reflecting long-term investments of $6.20 Million against total assets of $1.19 Billion USD.
Myriad Genetics Inc Long-term Investment Intensity by Year (2019–2022)
Myriad Genetics Inc long-term investment intensity by year from 2019 to 2022. The table below presents the year-by-year Long-term Investment Intensity for Myriad Genetics Inc from 2019 to 2022, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see MYGN total assets.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2022 | 4.6% | $54.80 Million | $1.20 Billion | ▲ +0.1 pp |
| 2021 | 4.5% | $59.00 Million | $1.32 Billion | ▲ +2.1 pp |
| 2019 | 2.4% | $37.00 Million | $1.56 Billion | — |